Independently assess launches and benchmark history of analogs.
Launch Dynamix™ provides granular tracking & benchmarking of brands for the first 18 months.
- Monthly benchmarking of newly launched products (first 18 months)
- Augmented by a quarterly deep dive into:
- Promotional activity
- Barriers to uptake
- Patient types gravitating to the launch brand
Methodology:
- Insights are based on analyses of quantitative data from an online survey of physicians recruited from the Spherix Network, as well as qualitative interviews with a subset of survey respondents.
Sample Size & Frequency:
- Monthly KPI benchmarking (n=75 physicians)
- Quarterly report (n=75 physicians)
- Quarterly qualitative interviews (n=8 physicians)
Reveal the ‘why’ behind treatment decisions and understand the patient journey.
Patient Chart Dynamix™ audits help you develop patient profiles and uncover opportunities.
- Capture data not available in claims by tapping into rigorous analysis of large-scale patient chart audits
- Understand differences between stated and actual treatment patterns with Specialists’ attitudinal & demographic data
- See how clinical trial populations compare to real patient management patterns and identify secondary endpoints that will allow for differentiation
Methodology:
- Insights are based on patient-level data gathered through collaboration with specialty physicians who provide details on clinical and non-clinical patient demographics, along with rationale for treatment choices.
Sample Size & Frequency:
- (sample sizes may vary based on inclusion criteria)
- US Annual Report (n=1,000 charts, n=200 physicians)
- EU5 Annual Report (n=1,250 charts, n=250 physicians)